Abstract
Despite their structural similarity, the two anti-influenza adamantane compounds amantadine (AMA) and rimantadine (RIM) exhibit strikingly different rates of blood-brain barrier (BBB) transport. However, the molecular mechanisms facilitating the higher rate of in situ BBB transport of RIM, relative to AMA, remain unclear. The aim of this study, therefore, was to determine whether differences in the extent of brain uptake between these two adamantanes also occurred in vivo, and elucidate the potential carrier protein facilitating their BBB transport using immortalized human brain endothelial cells (hCMEC/D3). Following oral administration to Swiss Outbred mice, RIM exhibited 2.4-3.0-fold higher brain-to-plasma exposure compared to AMA, which was not attributable to differences in the degree of plasma protein binding. At concentrations representative of those obtained in vivo, the hCMEC/D3 cell uptake of RIM was 4.5-15.7-fold higher than that of AMA, with Michaelis-Menten constants 6.3 and 238.4 μM, respectively. The hCMEC/D3 cellular uptake of both AMA and RIM was inhibited by various cationic transporter inhibitors (cimetidine, choline, quinine, and tetraethylammonium) and was dependent on extracellular pH, membrane depolarizat...Continue Reading
References
Nov 1, 1978·Experimental Neurology·T W Stone
Apr 25, 1991·European Journal of Pharmacology·J KornhuberP Riederer
Jun 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·A J Bailer
Sep 11, 1969·The New England Journal of Medicine·W L WingfieldR R Grunert
Mar 1, 1983·Antimicrobial Agents and Chemotherapy·F G HaydenD A Spyker
Sep 2, 1982·The New England Journal of Medicine·R DolinJ Webber-Jones
Feb 1, 1981·Antimicrobial Agents and Chemotherapy·F G HaydenB Giordani
May 22, 1998·Neurology·L Verhagen MetmanT N Chase
Jun 10, 1998·Biochemical and Biophysical Research Communications·X WuV Ganapathy
Aug 1, 1998·The Journal of Biological Chemistry·I TamaiA Tsuji
Aug 4, 1998·Molecular Pharmacology·A E BuschH Koepsell
Feb 27, 1999·Clinical Neuropharmacology·V G EvidenteK Gwinn-Hardy
Aug 14, 1999·The Journal of Biological Chemistry·J L Sloan, S Mager
May 29, 2000·Archives of Internal Medicine·L A KeyserJ S Bertino
Apr 18, 2001·The Journal of Clinical Investigation·T HatanakaM E Ganapathy
Apr 18, 2001·The Journal of Physiology·T NakanishiV Ganapathy
Dec 12, 2001·Journal of Neurochemistry·Y KidoA Tsuji
Nov 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kerry B GoralskiDaniel S Sitar
Nov 18, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takahiro HatanakaMalliga E Ganapathy
Aug 5, 2004·Pharmaceutical Research·Nagavedi S UmapathyMalliga E Ganapathy
Nov 5, 2004·Journal of Neurochemistry·Vincent BerezowskiKatarzyna A Nałecz
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jae B Park
Jul 20, 2005·Molecular Pharmaceutics·Blisse Jain-VakkalagaddaAshim K Mitra
Sep 6, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·B B WekslerP O Couraud
Oct 21, 2005·American Journal of Physiology. Cell Physiology·Gerhard J WeberJohn N Forrest
Jan 18, 2006·The Journal of Pharmacology and Experimental Therapeutics·Peng HsiaoJashvant D Unadkat
May 3, 2007·Pharmaceutical Research·Hermann KoepsellChristopher Volk
Jun 5, 2008·The Biochemical Journal·Senthil KarunakaranVadivel Ganapathy
Sep 6, 2008·Biochemical and Biophysical Research Communications·Magdalena CzeredysKatarzyna A Nałecz
Nov 18, 2008·Journal of Neurochemistry·Birk PollerJörg Huwyler
Jan 31, 2009·The Journal of Pharmacology and Experimental Therapeutics·Amber DahlinJoanne Wang
May 22, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Pascal AndréSalvatore Cisternino
May 19, 2010·Journal of Neurochemistry·Chun-Jung LinHorng-Huei Liou
Jun 29, 2011·Molecular Pharmaceutics·Ramzi ShawahnaJean-Michel Scherrmann
Citations
Jun 30, 2012·Pharmaceutical Research·Christel A S BergströmJoseph A Nicolazzo
Mar 28, 2013·Fluids and Barriers of the CNS·Babette WekslerPierre-Olivier Couraud
Jan 29, 2013·Fluids and Barriers of the CNS·Keita ShimomuraYoshiharu Deguchi
Jul 24, 2013·Drug Metabolism and Pharmacokinetics·Takashi OkuraYoshiharu Deguchi
Dec 5, 2012·Drug Discovery Today·Douglas B KellStephen G Oliver
Nov 21, 2014·Biopharmaceutics & Drug Disposition·Toyofumi SuzukiKazuo Tomono
Jun 18, 2016·Journal of Pharmaceutical Sciences·Liang JinJoseph A Nicolazzo
May 6, 2016·Biopharmaceutics & Drug Disposition·Toyofumi SuzukiKazuo Tomono
Oct 9, 2013·Molecular Pharmaceutics·Dharmini C MehtaJoseph A Nicolazzo
Apr 12, 2019·Biomolecules & Therapeutics·Asmita GyawaliYoung-Sook Kang
Feb 2, 2013·The Oncologist·Leslie S KersunKathleen E Sullivan
Dec 20, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne T NiesMatthias Schwab